Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Colorectal Neoplasms × Mesna × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Hematologic Neoplasms 5 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Hodgkin Disease 4 Breast Neoplasms 4 Leukemia, Myeloid, Acute 3 Leukemia 3 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Waldenstrom Macroglobulinemia 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Follicular 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Biphenotypic, Acute 1 Leukemia, B-Cell 1 Inflammatory Breast Neoplasms 1 Hematologic Diseases 1 Graft vs Host Disease 1 Colorectal Neoplasms 1 Burkitt Lymphoma 1 Bronchiolitis Obliterans Syndrome 1

Interventions

Cetuximab 39 Irinotecan 33 pembrolizumab 32 Oxaliplatin 32 Bevacizumab 32 Capecitabine 31 Fluorouracil 30 Leucovorin 29 Nivolumab 20 Gemcitabine 13 regorafenib 12 Cyclophosphamide 12 Folfox protocol 11 Cisplatin 10 Pemetrexed 9 Carboplatin 9 tislelizumab 8 Paclitaxel 8 IFL protocol 8 Panitumumab 7 130-nm albumin-bound paclitaxel 7 durvalumab 6 Ipilimumab 6 HMPL-013 6 Drug Therapy 6 irinotecan sucrosofate 5 Trifluridine 5 Specimen Handling 5 Interleukin-2 5 Everolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07255664 2025-12-08

ProbeTILity

Curacell Holding AB

Phase 1/2 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡